Resources
& Company News

Discover Isabella Schmitt's insightful perspective on the obstacles that prevent Houston from being recognized as one of the nation's leading life sciences hubs in her recent article featured on Houston Innovation Map!

Learn how to identify, minimize, and manage biases in AI for medical applications with this in-depth guide.

Learn from Isabella Schmitt, our Director of Regulatory Affairs, who is partnering with Galen Data to discuss, "Reducing AI Risk to Secure Regulatory Approval."

In the Wellness Device Playbook blog series, we’ll break down the qualifications, claims, and other related elements for marketing a device as a Wellness product.

CRO eyes growth with expanded office space in Houston's Texas Medical Center.

Let’s review the main elements for why, when and how to implement a quality management system. This is a key part of your MedTech or biotech product development.

Scientific panel of first-in-human clinics and investigators expands Proxima CRO's Phase I and II clinical trials offering with expert insight.

Learn a patient-centric approach to overcoming patient recruitment challenges in oncology clinical trials from our experts at Proxima Clinical Research, here!

A successful clinical trial depends on the recruitment and retention of patients, which can be challenging. Learn the strategies to implement in your study!

We work with innovative biotech & medical device companies across all phases of development; including writing your clinical trial protocol. Get to market quickly with our full suite of services.

ANEUVO, a platform and therapy development company, has initiated a clinical study of the ExaStim® TSS system, a wirelessly-controlled neuromodulation system designed to deliver transcutaneous spinal cord stimulation (TSS).

Do you know if your MedTech device should receive FDA Clearance or FDA Approval? How does this process work? Learn the process from our team of regulatory experts, here!

Proxima CRO is among 241 companies recognized for putting purpose before profit.

A quick summary of the life science industry investor news in 2022, and what the future holds for MedTech and biotech companies in 2023! Catch up on industry news in Kevin's newsletter.

After scouring the minds of a host of industry insiders and asking our readers for their take on looming events, Part B News compiled 10 predictions touching on coming changes, updates, upheavals and trends. Check out a Proxima expert's input.

Learn the latest news on the Theranos/Elizabeth Holmes trial that has captivated the public interest this year. learn what drug costs an arm and a leg and the status of life science companies scaling back - all in Kevin's newsletter.